scholarly journals Combining echo and natriuretic peptides to guide heart failure care in the outpatient setting: A position paper

2017 ◽  
Vol 47 (12) ◽  
pp. e12846 ◽  
Author(s):  
Frank L. Dini ◽  
Erberto Carluccio ◽  
Fabrizio Montecucco ◽  
Gian Marco Rosa ◽  
Paolo Fontanive
Keyword(s):  
Heart Failure ◽  
Natriuretic Peptides ◽  
Outpatient Setting ◽  
Position Paper ◽  
Heart Failure Care

Natriuretic Peptides – Addressing the Dilemma of Heart Failure Management

2011 ◽  
Vol 7 (2) ◽  
pp. 104
Author(s):  
Kenneth McDonald ◽  
Ulf Dahlström ◽  
◽  
Keyword(s):  
Heart Failure ◽  
Physical Examination ◽  
Natriuretic Peptides ◽  
Normal Values ◽  
Outpatient Setting ◽  
Heart Failure Management ◽  
Effective Screening ◽  
Specific Symptoms ◽  
Objective Marker

Heart failure (HF) is characterised by non-specific symptoms and unremarkable physical examination; therefore, the need exists for an available objective marker of HF status. Natriuretic peptides (NPs) are a marker that can aid the dilemmas in present-day HF management. More effective screening for clinical deterioration would include changes in brain natriuretic peptide (BNP) levels. Normal values for BNP, <50–100 pg/ml, have excellent negative predictive value (NPV) in excluding HF as a diagnosis. BNP values that are significantly elevated, e.g. >500 pg/ml, make the diagnosis of HF more likely. There are now established and emerging uses for NPs in managing HF in the community. These include the role of NPs at the time of possible new presentation of HF, its role in prognostication and, finally, the increasing interest in using NPs to guide therapy in the outpatient setting.

Sign in / Sign up

Export Citation Format

Share Document